Held on October 17, 2024 at IGCS 2024 Annual Global Meeting in Dublin, Ireland.
Chair(s): Susana Banerjee (United Kingdom), Donal J. Brennan (Ireland), Robert L. Coleman (United States of America), Antonio Gonzalez-Martín (Spain)
Patient Perspective
Case Presentation
Geetu Bhandoria (India)
Who Should Treat Ovarian Cancer?
Sudha Sundar (United Kingdom)
Biomarker Driven Therapy in Ovarian Cancer: Is It Prime Time?
Amit M. Oza (Canada)
First Line: Are We There Yet? Immunotherapy in Ovarian Cancer
Robert L. Coleman (United States of America)
The Challenge of Relapse: Role of Surgery in Oligometastatic Disease
Christina Fotopoulou (United Kingdom)
The Challenge of Relapse: Sterotactic RT in Oligometastatic Disease
Gabriella Macchia (Italy)
Q&A
What's on the Horizon With Novel Therapies?
Kathleen Moore (United States of America)
PARP Inhibitors in Recurrence
Jonathan A. Ledermann (United Kingdom)
MBO: Treatment Algorithms and Structured Ambulatory Management
Stephanie Lheureux (Canada)
MBO: Palliation
Michael Pearl (United States of America)